Details:

Alternative Title:
Emerg Infect Dis
Publisher's site:
http://dx.doi.org/10.3201/eid0909.020810
Personal Author:
Pérez-Trallero, Emilio; Marimon, José M.; Iglesias, Luis; Larruskain, Julián;
Pérez-Trallero, Emilio; Marimon, José M.; Iglesias, Luis; Larruskain, Julián; Less -
Description:
Streptococcus pneumoniae serotype 3, isolated from a penicillin-allergic patient and initially susceptible to fluoroquinolones, macrolides, lincosamides, quinupristin-dalfopristin, and telithromycin, became resistant to all these drugs during treatment. Mutations in the parC and gyrA and in the 23S rRNA and the ribosomal protein L22 genes were detected in the resistant isolates.
Subject:
[+]
Aged
Anti-Bacterial Agents
Anti-Infective Agents
Ciprofloxacin
Clarithromycin
Dispatch
Drug Resistance
Drug Resistance, Multiple, Bacterial
Fluoroquinolones
Humans
In Vivo Selection
Levofloxacin
Macrolides
Male
Microbial Sensitivity Tests
Pneumococcal Infections
Point Mutation
Quinupristin-dalfopristin
Serotype 3
Streptococcus Pneumoniae
Telithromycin
Treatment Failure
Treatment Failure

Source:
Emerg Infect Dis. 9(9):1159-1162.;
Document Type:
Journal Article;
Collection(s):
Emerging Infectious Diseases
Main Document Checksum:
[+]
urn:sha256:4e18786bc488eabe283661ee4866d4c61cd6b90bd09a667948e9ccff289688d1
File Type:

Supporting Files

• 	02-0810.nxml	txt
  	license.txt	txt

More +